Transcribed
Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT
Aug 1, 2024 ·
5m
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT
This is an automatically generated transcript. Please note that complete accuracy is not guaranteed.
Description
Recent Advances in Medical Technologies and Therapies: Stryker's innovative spine surgery technology receives FDA approval, OneMedNet raises $4.6 million in private funding, and the CHMP endorses RYBREVANT® (amivantamab) combined with...
show more
Recent Advances in Medical Technologies and Therapies: Stryker's innovative spine surgery technology receives FDA approval, OneMedNet raises $4.6 million in private funding, and the CHMP endorses RYBREVANT® (amivantamab) combined with chemotherapy for advanced EGFR-mutated NSCLC post-therapy failure.
show less
Information
| Author | Spod Media LLC |
| Organization | Spod Media |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
